Human Immunology

Papers
(The H4-Index of Human Immunology is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Genomic collision at the LIMS-1 locus increases risk of cellular mediated allograft rejection in heart transplanted recipients63
HLA tailored immunosuppression in living related pediatric kidney transplants in a low-income country. Cost and survival benefits58
Endothelial derived extracellular vesicles express high level of HLA class II molecules under inflammatory conditions32
Concentration-dependent antibody specificity profiles of human leukocyte DQ antigens and predictions of functional epitopes27
Simplified technique sensitive washing steps for a robust hybrid capture target enrichment NGS assay24
Power BI for HLA24
Novel null allele discovered by rapid next-gen sequencing24
Impact of Tocilizumab treatment on the reduction of angiotensin II type 1 receptor (AT1R) antibodies24
HLA-DR/DQ molecular mismatches for risk stratification and prediction of development of de novo donor-specific antibodies in cardiac allogeneic transplantation23
Donor specific antibodies to DQ antigens are rare in DR antigen matched kidney transplants19
Corrigendum to “Novel HLA-A, -B, -C and -DRB1 alleles identified in the Australian New South Wales tissue typing laboratory” [Hum. Immunol. 86 (3) (2025) 111275]17
A buccal swab DNA extraction method for Next Generation Sequencing17
P401 Successful removal of flow cytometry crossmatch interference by a novel rituximab biosimilar16
P210 The impact of HLA-DPB1 disparity on clinical outcome post unrelated hematopoietic stem cell transplantation between 2016 and 2021 – A single center experience16
Microarray analysis of autoantibodies can identify future Systemic Lupus Erythematosus patients16
P221 Identifying the specificity of non-HLA antibodies in flow cytometry crossmatch positive, HLA DSA negative patient sera15
0.31611490249634